These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
779 related articles for article (PubMed ID: 22090781)
1. Factors predicting occurrence and prognosis of hepatitis-B-virus-related hepatocellular carcinoma. Han YF; Zhao J; Ma LY; Yin JH; Chang WJ; Zhang HW; Cao GW World J Gastroenterol; 2011 Oct; 17(38):4258-70. PubMed ID: 22090781 [TBL] [Abstract][Full Text] [Related]
2. Viral and host inflammation-related factors that can predict the prognosis of hepatocellular carcinoma. Chen L; Zhang Q; Chang W; Du Y; Zhang H; Cao G Eur J Cancer; 2012 Sep; 48(13):1977-87. PubMed ID: 22325840 [TBL] [Abstract][Full Text] [Related]
3. Hepatitis B viral load affects prognosis of hepatocellular carcinoma. Yu SJ; Kim YJ World J Gastroenterol; 2014 Sep; 20(34):12039-44. PubMed ID: 25232241 [TBL] [Abstract][Full Text] [Related]
4. Role of hepatitis B virus genotype mixture, subgenotypes C2 and B2 on hepatocellular carcinoma: compared with chronic hepatitis B and asymptomatic carrier state in the same area. Yin J; Zhang H; Li C; Gao C; He Y; Zhai Y; Zhang P; Xu L; Tan X; Chen J; Cheng S; Schaefer S; Cao G Carcinogenesis; 2008 Sep; 29(9):1685-91. PubMed ID: 18192693 [TBL] [Abstract][Full Text] [Related]
5. Clinical relevance and public health significance of hepatitis B virus genomic variations. Cao GW World J Gastroenterol; 2009 Dec; 15(46):5761-9. PubMed ID: 19998495 [TBL] [Abstract][Full Text] [Related]
6. Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma. Yang HI; Yeh SH; Chen PJ; Iloeje UH; Jen CL; Su J; Wang LY; Lu SN; You SL; Chen DS; Liaw YF; Chen CJ; J Natl Cancer Inst; 2008 Aug; 100(16):1134-43. PubMed ID: 18695135 [TBL] [Abstract][Full Text] [Related]
7. Viral load, genotypes, and mutants in hepatitis B virus-related hepatocellular carcinoma: special emphasis on patients with early hepatocellular carcinoma. Chu CM; Lin CC; Lin SM; Lin DY; Liaw YF Dig Dis Sci; 2012 Jan; 57(1):232-8. PubMed ID: 21837473 [TBL] [Abstract][Full Text] [Related]
8. Effect of functional nuclear factor-kappaB genetic polymorphisms on hepatitis B virus persistence and their interactions with viral mutations on the risk of hepatocellular carcinoma. Zhang Q; Ji XW; Hou XM; Lu FM; Du Y; Yin JH; Sun XY; Deng Y; Zhao J; Han X; Yang GS; Zhang HW; Chen XM; Shen HB; Wang HY; Cao GW Ann Oncol; 2014 Dec; 25(12):2413-2419. PubMed ID: 25223483 [TBL] [Abstract][Full Text] [Related]
9. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma. Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206 [TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus-induced hepatocellular carcinoma. Xu C; Zhou W; Wang Y; Qiao L Cancer Lett; 2014 Apr; 345(2):216-22. PubMed ID: 23981576 [TBL] [Abstract][Full Text] [Related]
12. Human cytidine deaminases facilitate hepatitis B virus evolution and link inflammation and hepatocellular carcinoma. Deng Y; Du Y; Zhang Q; Han X; Cao G Cancer Lett; 2014 Feb; 343(2):161-71. PubMed ID: 24120759 [TBL] [Abstract][Full Text] [Related]
14. Distribution and hepatocellular carcinoma-related viral properties of hepatitis B virus genotypes in Mainland China: a community-based study. Yin J; Zhang H; He Y; Xie J; Liu S; Chang W; Tan X; Gu C; Lu W; Wang H; Bi S; Cui F; Liang X; Schaefer S; Cao G Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):777-86. PubMed ID: 20160279 [TBL] [Abstract][Full Text] [Related]
15. Etiological and molecular profile of hepatocellular cancer from India. Asim M; Sarma MP; Kar P Int J Cancer; 2013 Jul; 133(2):437-45. PubMed ID: 23233429 [TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of hepatitis B virus isolated from Black South African cancer patients, with and without hepatocellular carcinoma. Mak D; Kramvis A Arch Virol; 2020 Aug; 165(8):1815-1825. PubMed ID: 32504396 [TBL] [Abstract][Full Text] [Related]
17. The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targets. Ringelhan M; O'Connor T; Protzer U; Heikenwalder M J Pathol; 2015 Jan; 235(2):355-67. PubMed ID: 25196558 [TBL] [Abstract][Full Text] [Related]
18. Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis. Liu S; Zhang H; Gu C; Yin J; He Y; Xie J; Cao G J Natl Cancer Inst; 2009 Aug; 101(15):1066-82. PubMed ID: 19574418 [TBL] [Abstract][Full Text] [Related]
19. [Risk factors analysis and a new risk scoring system predicting hepatocarcinogenesis for chronic genotype C HBV infected patients]. Liu JL; Pu R; Ma LT; Wang S; Yin JH; Cao GW Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Nov; 39(11):1459-1464. PubMed ID: 30462954 [No Abstract] [Full Text] [Related]
20. The Influence of Hepatitis B Viral Load and Pre-S Deletion Mutations on Post-Operative Recurrence of Hepatocellular Carcinoma and the Tertiary Preventive Effects by Anti-Viral Therapy. Su CW; Chiou YW; Tsai YH; Teng RD; Chau GY; Lei HJ; Hung HH; Huo TI; Wu JC PLoS One; 2013; 8(6):e66457. PubMed ID: 23805222 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]